Perception Towards COVID-19 and Its Vaccination: Acceptance and Concerns Among the General Population of Sargodha, Pakistan

Author(s)

Tariq I1, Azhar S2, Hussain S1, Ahmed J3, Chaudhry B2, Sundus A1
1University of Sargodha, Sargodha, Pakistan, 2University of Sargodha, Sargodha, PB, Pakistan, 3University of Sargodha, Quetta, Pakistan

OBJECTIVES: This study is focused on examining people's perceptions regarding attitudes, knowledge, acceptance and concerns of COVID-19 and its rushed approved vaccine.

METHODS: A quantitative research study was conducted among the general population of Sargodha which were present at government approved vaccination centers. A total 470 questionnaires were distributed and received 400 in return. A 27-item valid questionnaire was developed. The IBM SPSS version 25 Software was used for the statistical analysis. Descriptive statistics have been applied thus frequency and percentages were documented against each item. Chi-square test was also applied to assess the association between knowledge, attitude, practices, acceptance and concerns within socio-demographics.

RESULTS: This study shows majority was below 25 years of age 35% and 42.3% were holding a graduate degree. The study reveals that 60.5% males were present at vaccination centers followed by 66% participants belonged to Sargodha. About 47.5% considered social media as preferred medium on providing information related to COVID-19 and its vaccination. About half of the participants 45.5% agreed that COVID-19 vaccine will be useful in protecting them against COVID-19 infection. Approximately half of participants 45.5% showed their concern regarding the rapid and quick approval of COVID-19 vaccine.

CONCLUSIONS: General public of Sargodha demonstrated an overall adequate knowledge and good perception towards COVID-19 and has accepted its vaccination and only showed their concern on the rapid development of its vaccination.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Code

EPH133

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×